Variables | All (N = 315) | Group I (N = 88) | Group II (N = 167) | Group III (N = 60) | P value |
---|---|---|---|---|---|
ICU duration (days) | 1 (1–22) | 1 (1–6) | 1 (1–22) | 1 (1–7) | 0.01 |
Hospital stay (days) | 5 (2–66) | 5 (5–22) | 5 (2–31) | 6 (3–66) | 0.002 |
Morbidity | 158 (50.2%) | 36 (40.9%) | 83 (49.7%) | 39 (65%) | 0.016 |
Clavien-Dindo grade | Â | Â | Â | Â | 0.87 |
 I | 66 (21%) | 16 (18.2%) | 36 (21.6%) | 14 (23.3%) | |
 II | 47 (14.9%) | 10 (11.4%) | 25 (15%) | 12 (20%) | |
 III-a | 14 (4.4%) | 3 (3.4%) | 9 (5.4%) | 2 (3.3%) | |
 III-b | 11 (3.5%) | 2 (2.3%) | 5 (3%) | 4 (6.7%) | |
 IV-a | 2 (0.6%) | 1 (1.1%) | 0 | 1 (1.7%) | |
 V | 18 (5.7%) | 4 (4.5%) | 8 (4.8%) | 6 (10%) | |
Morbidity type | Â | Â | Â | Â | 0.064 |
 General | 4 (1.3%) | 0 | 1 (0.6%) | 3 (5%) | |
 Surgical | 8 (2.5%) | 2 (2.3%) | 6 (3.6%) | 0 | |
 Liver-related | 110 (34.9%) | 26 (29.5%) | 61 (36.5%) | 23 (38.3%) | |
 Mixed | 36 (11.4%) | 8 (9.1%) | 15 (9%) | 13 (1.7%) | |
 PHLF | 142 (45.1%) | 32 (36.4%) | 74 (44.3%) | 36 (60%) | 0.017 |
PHLF grade | Â | Â | Â | Â | 0.643 |
 A | 81 (25.7%) | 18 (20.5%) | 46 (27.5%) | 17 (28.3%) | |
 B | 41 (13%) | 10 (11.4%) | 19 (11.4%) | 12 (20%) | |
 C | 20 (6.3%) | 4 (4.5%) | 9 (5.4%) | 7 (11.7%) | |
Bile leakage | 17 (5.4%) | 5 (5.7%) | 8 (4.8%) | 4 (6.7%) | 0.851 |
Bile leakage treatment | Â | Â | Â | Â | 0.255 |
 Conservative | 6 (1.9%) | 2 (2.3%) | 4 (2.4%) | 0 | |
 US guided tube | 3 (1%) | 1 (1.1%) | 2 (1.2%) | 0 | |
 ERCP | 7 (2.2%) | 2 (2.3%) | 2 (1.2%) | 3 (5%) | |
 Operative | 1 (0.3%) | 0 | 0 | 1 (1.7%) | |
Collection | 16 (5.1%) | 4 (4.5%) | 7 (4.2%) | 5 (8.3%) | 0.44 |
Collection treatment | Â | Â | Â | Â | 0.176 |
 Conservative | 6 (1.9%) | 2 (2.3%) | 1 (0.6%) | 3 (5%) | |
 US guided tube | 9 (2.9%) | 2 (2.3%) | 6 (3.6%) | 1 (1.7%) | |
 Operative | 1 (0.3%) | 0 | 0 | 1 (1.7%) | |
Internal hemorrhage Managed surgically | 7 (2.2%) | 1 (1.1%) | 4 (2.4%) | 2 (3.3%) | 0.657 |
Wound infection All bed side management | 9 (2.9%) | 2 (2.3%) | 4 (2.4%) | 3 (5%) | 0.541 |
Liver Abscess All US guided drainage | 3 (1%) | 2 (2.3%) | 1 (0.6%) | 0 | 0.298 |
Vascular complications (PVT) | 5 (1.6%) | 0 | 3 (1.8%) | 2 (3.3%) | 0.268 |
Respiratory complications | 17 (5.4%) | 5 (5.7%) | 5 (3%) | 7 (11.7%) | 0.038 |
Pleural effusion | 16 (5.1%) | 5 (5.7%) | 4 (2.4%) | 7 (11.7%) | 0.279 |
Pneumonia | 1 (0.3%) | 0 | 1 (0.6%) | 0 | |
Respiratory treatment | Â | Â | Â | Â | 0.189 |
 Conservative | 13 (4.1%) | 3 (3.4%) | 4 (2.4%) | 6 (10%) | |
 US guided drainage | 4 (1.3%) | 2 (2.3%) | 1 (0.6%) | 1 (1.7%) | |
Cardiac dysrhythmia | 1 (0.3%) | 0 | 0 | 1 (1.7%) | 0.119 |
Renal complications (hepato-renal syndrome) | 4 (1.3%) | 2 (2.3%) | 2 (1.2%) | 0 | 0.476 |
Cerebral stroke | 1 (0.3%) | 0 | 1 (0.6%) | 0 | 0.641 |
Ileus | 1 (0.3%) | 0 | 0 | 1 (1.7%) | 0.119 |
Bleeding varices Endoscopic management | 1 (0.3%) | 0 | 1 (0.6%) | 0 | 0.641 |
Early mortality | 20 (6.3%) | 4 (4.5%) | 9 (5.4%) | 7 (11.7%) | 0.166 |
Early mortality cause Liver failure | 20 (6.3%) | 4 (4.5%) | 9 (5.4%) | 7 (11.7%) | 0.166 |